HONEYWELL INTERNATIONAL INC: Honeywell Sharpens Focus: What Investors Need to Know About Recent Portfolio Changes and Impairment Charges

Honeywell International Inc. (HON) is making a strategic move to sharpen its focus on core automation, and investors need to understand the financial implications. The company recently announced significant non-cash impairment charges as it prepares to divest two business units: Productivity Solutions and Services (PSS) and Warehouse and Workflow Solutions (WWS). These details emerged in their annual report (Form 10-K), filed with the SEC on February 17, 2026.

Event Description

Honeywell is selling its PSS and WWS business units. As part of this process, the company reduced the value of these businesses on its financial books, a step known as an "impairment charge." While Honeywell announced initial charges in January, it now reports additional non-cash impairment charges totaling $471 million for fiscal year 2025. This amount includes $436 million for "goodwill" (the value of a company's brand and customer relationships) and $35 million for the underlying assets of these units. A $61 million tax benefit partially offset these charges.

Event Date/Timeline

Honeywell first classified PSS and WWS as "held for sale" in the fourth quarter of 2025. The company disclosed the initial financial impact in a press release on January 29, 2026, alongside its year-end results. These additional impairment charges became public yesterday, February 17, 2026, when Honeywell filed its annual report (Form 10-K) with the SEC.

Impact Assessment

This divestiture is a key part of Honeywell's "ongoing portfolio optimization strategy." By selling PSS and WWS, the company aims to focus resources on its "core automation portfolio," targeting higher-growth, higher-margin opportunities in automated systems and technology. This signals a clear strategic shift toward a more focused and potentially more efficient Honeywell.

Impairment charges occur when an asset's estimated fair value (like a business unit being sold) falls below its recorded value on the company's balance sheet. The recognition of additional charges suggests Honeywell further revised its estimates downwards for the potential sale price or future value of these businesses during the ongoing sale process.

Financial Impact

This is crucial for investors:

• Reported (GAAP) Earnings Impact: The $471 million in non-cash impairment charges significantly lower Honeywell's reported (GAAP) profits for 2025. For example, Honeywell revised earnings per share from continuing operations to $6.94, and the operating margin to 14.9%. To put this in perspective, without these additional charges, GAAP EPS would have been approximately $7.50, and the operating margin around 16.0%. While these are non-cash charges (meaning no new money leaves the company's bank accounts), they directly reduce the company's reported net income and asset values.
• Crucial Distinction: Adjusted Results Unchanged: Honeywell states that these additional charges DO NOT alter its previously announced adjusted financial results for 2025 or its financial forecast (guidance) for 2026. Adjusted results typically exclude one-time events like impairment charges to provide a clearer picture of the company's ongoing operational performance. This indicates management believes the core business performs as expected, and the future outlook remains stable despite the accounting adjustment.

Key Takeaways for Investors

Honeywell expects to announce the sale of PSS and WWS in the first half of 2026. Investors should monitor for details on potential buyers, final sale prices, and regulatory approvals.

• Understand the Nuance: Distinguish between reported (GAAP) earnings, which these one-time charges impact, and adjusted earnings, which reflect the ongoing health of the business and remain unchanged.
• Long-Term Strategy: View this as a strategic portfolio optimization designed to enhance long-term growth and profitability by focusing on core strengths.
• Monitor Sale Progress: The ultimate financial benefit (or cost) of these divestitures depends on the final sale terms. Keep an eye out for updates in the first half of 2026.
• Potential Risks: While strategic, the sale process could take longer or the final sale price might be lower than anticipated, though impairment charges already reflect a revised valuation.